BeyondSpring Inc (BYSI) - Net Assets
Based on the latest financial reports, BeyondSpring Inc (BYSI) has net assets worth $-23.99 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($25.93 Million) and total liabilities ($49.92 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BYSI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-23.99 Million |
| % of Total Assets | -92.51% |
| Annual Growth Rate | N/A |
| 5-Year Change | -214.66% |
| 10-Year Change | -295.06% |
| Growth Volatility | 123.74 |
BeyondSpring Inc - Net Assets Trend (2014–2025)
This chart illustrates how BeyondSpring Inc's net assets have evolved over time, based on quarterly financial data. Also explore BYSI total assets for the complete picture of this company's asset base.
Annual Net Assets for BeyondSpring Inc (2014–2025)
The table below shows the annual net assets of BeyondSpring Inc from 2014 to 2025. For live valuation and market cap data, see BeyondSpring Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-23.99 Million | -67.94% |
| 2024-12-31 | $-14.29 Million | +39.11% |
| 2023-12-31 | $-23.46 Million | -680.21% |
| 2022-12-31 | $-3.01 Million | -114.37% |
| 2021-12-31 | $20.92 Million | -77.21% |
| 2020-12-31 | $91.82 Million | +194.95% |
| 2019-12-31 | $31.13 Million | +431.82% |
| 2018-12-31 | $-9.38 Million | -133.46% |
| 2017-12-31 | $28.04 Million | +127.95% |
| 2016-12-31 | $12.30 Million | +27.35% |
| 2015-12-31 | $9.66 Million | +202.82% |
| 2014-12-31 | $-9.39 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to BeyondSpring Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 39628300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | % |
| Other Comprehensive Income | $602.00K | % |
| Other Components | $375.66 Million | % |
| Total Equity | $-32.16 Million | 100.00% |
BeyondSpring Inc Competitors by Market Cap
The table below lists competitors of BeyondSpring Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TsannKuen (China) Enterprise Co. Ltd
SHE:200512
|
$61.29 Million |
|
Commercial Vehicle Group Inc
NASDAQ:CVGI
|
$61.34 Million |
|
AGRONOMICS LTD.LS-0000001
F:V77
|
$61.37 Million |
|
Linz Textil Holding AG
VI:LTH
|
$61.38 Million |
|
Lion Chemtech Co. Ltd
KQ:171120
|
$61.23 Million |
|
Altinyag Kombinalari AS
IS:ALMAD
|
$61.22 Million |
|
Pansar Bhd
KLSE:8419
|
$61.22 Million |
|
T7 Global Bhd
KLSE:7228
|
$61.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BeyondSpring Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -32,900,000 to -32,161,000, a change of 739,000.
- Net loss of 7,992,000 reduced equity.
- New share issuances of 2,000,000 increased equity.
- Other comprehensive income decreased equity by 734,000.
- Other factors increased equity by 7,465,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.99 Million | -24.85% |
| Share Issuances | $2.00 Million | +6.22% |
| Other Comprehensive Income | $-734.00K | -2.28% |
| Other Changes | $7.46 Million | +23.21% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares BeyondSpring Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $-0.59 | $1.49 | x |
| 2015-12-31 | $0.57 | $1.49 | x |
| 2016-12-31 | $0.72 | $1.49 | x |
| 2017-12-31 | $1.30 | $1.49 | x |
| 2018-12-31 | $-0.34 | $1.49 | x |
| 2019-12-31 | $1.23 | $1.49 | x |
| 2020-12-31 | $2.95 | $1.49 | x |
| 2021-12-31 | $0.54 | $1.49 | x |
| 2022-12-31 | $-0.15 | $1.49 | x |
| 2023-12-31 | $-0.69 | $1.49 | x |
| 2024-12-31 | $-0.83 | $1.49 | x |
| 2025-12-31 | $-0.80 | $1.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BeyondSpring Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-85.69%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.07 Million |
| 2015 | -89.05% | 0.00% | 0.00x | 1.23x | $-8.87 Million |
| 2016 | -98.83% | 0.00% | 0.00x | 1.23x | $-13.23 Million |
| 2017 | -338.91% | 0.00% | 0.00x | 1.21x | $-94.47 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-54.09 Million |
| 2019 | -125.79% | 0.00% | 0.00x | 1.47x | $-41.11 Million |
| 2020 | -69.02% | -33873.89% | 0.00x | 1.32x | $-69.81 Million |
| 2021 | -306.74% | -4750.48% | 0.02x | 3.90x | $-66.27 Million |
| 2022 | 0.00% | -2463.29% | 0.03x | 0.00x | $-32.68 Million |
| 2023 | 0.00% | -1200.80% | 0.07x | 0.00x | $-18.35 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-7.83 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.78 Million |
Industry Comparison
This section compares BeyondSpring Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $44,828,400
- Average return on equity (ROE) among peers: -124.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BeyondSpring Inc (BYSI) | $-23.99 Million | 0.00% | N/A | $61.27 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-54.64 Million | 0.00% | 0.00x | $118.88 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $1.07 Billion |
| Abeona Therapeutics Inc (ABEO) | $3.60 Million | -91.89% | 0.28x | $292.09 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $266.97 Million | -19.62% | 0.16x | $171.87 Million |
| Abpro Holdings, Inc. (ABP) | $3.07 Million | -479.81% | 1.57x | $448.19K |
| Absci Corp (ABSI) | $67.00 Million | -21.42% | 0.32x | $345.85 Million |
| Arbutus Biopharma Corp (ABUS) | $88.00 Million | -44.09% | 0.34x | $840.56 Million |
| ABVC Biopharma Inc (ABVC) | $80.00K | -31.70% | 0.38x | $26.41 Million |
| Abivax SA American Depositary Shares (ABVX) | $40.58 Million | -434.26% | 4.06x | $9.33 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $23.36 Million | -97.44% | 0.37x | $3.74 Billion |
About BeyondSpring Inc
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-canc… Read more